Effect of naturally occurring α-synuclein-antibodies on toxic α-synuclein-fragments.

• Naturally occurring autoantibodies against human α-Syn (nAbs α-Syn) were detected in the peripheral blood of PD patients and controls in different levels. • We investigated the inhibitory effect of nAbs α-Syn on distinct α-Syn fragments induced inflammation and cytotoxicity on pr0imary microglia. • All α-Syn fragments induced the release of the pro-inflammatory cytokines interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-α) from primary cultured microglia. • Cotreatment with nAbs α-Syn did alleviate the release of pro-inflammatory cytokines induced by the α-Syn fragments α-Syn 1–95, α-Syn 61–140, α-Syn 96–140 and α-Syn 112. • Treatment with the α-Syn fragments α-Syn 1–95, α-Syn 61–140 and α-Syn 112 impaired the viability of primary microglia. This effect could not be counteracted by cotreatment with nAbs α-Syn. Alpha-synuclein (α-Syn) is a soluble protein primarily expressed in presynaptic terminals in the central nervous system (CNS). Aggregates of fibrillated α-Syn are the major component of Lewy bodies (LB), a pathologic hallmark of idiopathic Parkinson's disease (PD). Recently, naturally occurring autoantibodies against human α-Syn (nAbs α-Syn) were detected in the peripheral blood of PD patients and controls. Here, we investigated the inhibitory effects of nAbs α-Syn on distinct α-Syn fragments, as well as inflammatory responses and cytotoxicity evoked by nAbs α-Syn in primary microglia. All α-Syn fragments induced the release of the pro-inflammatory cytokines interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF-α) from microglia in primary culture. Cotreatment with nAbs α-Syn alleviated the release of pro-inflammatory cytokines induced by α-Syn fragments α-Syn 1–95, α-Syn 61–140, α-Syn 96–140 and α-Syn 112. Treatment with the α-Syn fragments α-Syn 1–95, α-Syn 61–140 and α-Syn 112 impaired the viability of primary microglia. This effect could not be counteracted by cotreatment with nAbs α-Syn. Data suggest an important role of nAbs α-Syn in the α-Syn-induced inflammation cascade, and indicate the potential importance of nAbs in the pathogenesis of PD. This could provide an experimental therapeutic target for patients with PD. [ABSTRACT FROM AUTHOR]